Leerink Swann Comments on CVS Health Corp’s FY2019 Earnings (NYSE:CVS)
CVS Health Corp (NYSE:CVS) – Stock analysts at Leerink Swann raised their FY2019 earnings estimates for shares of CVS Health in a research note issued on Thursday, September 20th, according to Zacks Investment Research. Leerink Swann analyst D. Larsen now expects that the pharmacy operator will earn $7.55 per share for the year, up from their prior estimate of $7.45. Leerink Swann has a “Outperform” rating and a $80.00 price objective on the stock.
CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 8th. The pharmacy operator reported $1.69 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.61 by $0.08. CVS Health had a return on equity of 18.25% and a net margin of 1.61%. The business had revenue of $46.71 billion for the quarter, compared to the consensus estimate of $46.34 billion. During the same period last year, the business earned $1.33 EPS. The firm’s revenue was up 2.2% compared to the same quarter last year.
Shares of CVS stock traded up $1.39 during trading on Friday, reaching $74.58. The company had a trading volume of 9,475,196 shares, compared to its average volume of 8,231,727. The company has a debt-to-equity ratio of 1.73, a quick ratio of 1.87 and a current ratio of 2.34. CVS Health has a one year low of $60.14 and a one year high of $83.88. The company has a market capitalization of $80.14 billion, a price-to-earnings ratio of 12.64, a PEG ratio of 1.05 and a beta of 1.02.
Several institutional investors and hedge funds have recently added to or reduced their stakes in CVS. Camarda Financial Advisors LLC acquired a new stake in CVS Health in the 2nd quarter valued at $102,000. Canton Hathaway LLC acquired a new stake in CVS Health in the 3rd quarter valued at $126,000. Kiley Juergens Wealth Management LLC acquired a new stake in CVS Health in the 2nd quarter valued at $103,000. Quantbot Technologies LP acquired a new stake in CVS Health in the 1st quarter valued at $103,000. Finally, Legacy Advisors LLC boosted its stake in CVS Health by 7,100.0% in the 2nd quarter. Legacy Advisors LLC now owns 1,800 shares of the pharmacy operator’s stock valued at $116,000 after buying an additional 1,775 shares in the last quarter. Institutional investors and hedge funds own 82.75% of the company’s stock.
In other news, EVP Kevin Hourican sold 8,564 shares of the business’s stock in a transaction that occurred on Monday, August 27th. The stock was sold at an average price of $75.00, for a total transaction of $642,300.00. Following the sale, the executive vice president now directly owns 12,135 shares in the company, valued at $910,125. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Eva C. Boratto sold 13,311 shares of the business’s stock in a transaction that occurred on Monday, September 17th. The shares were sold at an average price of $77.16, for a total value of $1,027,076.76. Following the sale, the executive vice president now owns 55,162 shares in the company, valued at $4,256,299.92. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 43,409 shares of company stock worth $3,392,097. Company insiders own 0.53% of the company’s stock.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 1st. Shareholders of record on Wednesday, October 24th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.68%. The ex-dividend date is Tuesday, October 23rd. CVS Health’s dividend payout ratio is currently 33.90%.
About CVS Health
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
See Also: What is a Call Option?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.